Bone Morphogenetic Protein-7 and Connective Tissue Growth Factor: Novel Targets for Treatment of Renal Fibrosis?
Open Access
- 12 February 2008
- journal article
- review article
- Published by Springer Nature in Pharmaceutical Research
- Vol. 25 (10), 2416-2426
- https://doi.org/10.1007/s11095-008-9548-9
Abstract
Renal fibrosis is the major determinant in progression of kidney disease and results from an inappropriate response to acute and chronic kidney injury. Transforming growth factor (TGF)-β1 is the driving force behind renal fibrosis and has since long been regarded as the key factor to be targeted in prevention and treatment of renal fibrosis. Despite the impressive results obtained in experimental renal fibrosis, TGF-β1 blockade has not yet translated into an effective and safe therapeutic in human patients. Therefore, it remains important to explore the role of additional growth factors which are involved in renal regeneration and fibrosis. Recently, bone morphogenetic protein (BMP)-7 and connective tissue growth factor (CTGF) have both emerged as novel modulators of profibrotic TGF-β1 activity. The expression of BMP-7 is decreased in various models of renal disease, while CTGF is strongly upregulated in experimental and human renal fibrosis. In experimental kidney injury, administration of BMP-7 or inhibition of CTGF have been sufficient to result in striking improvement of renal function and structure. This review summarizes the current knowledge of BMP-7 and CTGF in the kidney, and discusses their therapeutic potential in renal fibrosis.Keywords
This publication has 161 references indexed in Scilit:
- Connective tissue growth factor with a novel fibronectin binding site promotes cell adhesion and migration during rat oval cell activationHepatology, 2008
- A Human Bone Morphogenetic Protein Antagonist Is Down-Regulated in Renal CancerMolecular Biology of the Cell, 2008
- BMP-2 promotes phosphate uptake, phenotypic modulation, and calcification of human vascular smooth muscle cellsAtherosclerosis, 2008
- Clinical applications of BMP-7/OP-1 in fractures, nonunions and spinal fusionInternational Orthopaedics, 2007
- BMP‐7 functions as a novel hormone to facilitate liver regenerationThe FASEB Journal, 2006
- Inhibition of endogenous BMP in the glomerulus leads to mesangial matrix expansionBiochemical and Biophysical Research Communications, 2006
- BMP4 substitutes for loss of BMP7 during kidney developmentDevelopmental Biology, 2005
- Identification of human ccn2 (connective tissue growth factor) promoter polymorphismsMolecular Pathology, 2001
- A requirement for bone morphogenetic protein-7 during development of the mammalian kidney and eye.Genes & Development, 1995
- TGF-β stimulation and inhibition of cell proliferation: New mechanistic insightsCell, 1990